Literature DB >> 7649617

Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.

W F Blakemore1, A J Crang, R J Franklin, K Tang, S Ryder.   

Abstract

Transplantation of glial cells into demyelinating lesions in CNS offers an experimental approach which allows investigation of the complex interactions that occur between CNS glia, Schwann cells, and axons during remyelination and repair. Earlier studies have shown that 1) transplanted astrocytes are able to prevent Schwann cells from participating in CNS remyelination, but that they are only able to do so with the cooperation of cells of the oligodendrocyte lineage, and 2) transplanted mouse oligodendrocytes can remyelinate rat axons provided their rejection is controlled by immunosuppression. On the basis of these observations, we have been able to prevent the Schwann cell remyelination that normally follows ethidium bromide demyelination in the rat spinal cord by co-transplanting isogeneic astrocytes with a potentially rejectable population of mouse oligodendrocyte lineage cells. Since male mouse cells were used it was possible to demonstrate their presence in immunosuppressed recipients using a mouse Y-chromosome probe by in situ hydridisation. When myelinating mouse cells were rejected by removal of immunosuppression, the demyelinated axons were remyelinated by host oligodendrocytes rather than Schwann cells, whose entry was prevented by the persistence of the transplanted isogeneic astrocytes. The oligodendrocyte remyelination was extensive and rapid, indicating that the inflammation associated with cell rejection did not impede repair. If this host oligodendrocyte remyelination was prevented by local X-irradiation, the lesion consisted of demyelinated axons surrounded by processes from the transplanted astrocytes. By this approach, it was possible to create an environment which resembled the chronic plaques of multiple sclerosis. Thus, these experiments demonstrate that in appropriate circumstances the temporary presence of a population of glial cells can alter the outcome of damage to the CNS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649617     DOI: 10.1002/glia.440130202

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  4 in total

1.  A quantitative morphometric analysis of rat spinal cord remyelination following transplantation of allogenic Schwann cells.

Authors:  Karen L Lankford; Toshio Imaizumi; Osamu Honmou; Jeffery D Kocsis
Journal:  J Comp Neurol       Date:  2002-02-11       Impact factor: 3.215

Review 2.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

3.  Accelerated myelination associated with venous congestion.

Authors:  L Porto; M Kieslich; B Yan; F E Zanella; H Lanfermann
Journal:  Eur Radiol       Date:  2005-10-28       Impact factor: 5.315

4.  Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response.

Authors:  Jenny L Hardison; Gabriel Nistor; Rafael Gonzalez; Hans S Keirstead; Thomas E Lane
Journal:  Exp Neurol       Date:  2005-11-17       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.